BG104150A - PYRAZOLO(3,4-d)PYRIMIDINES WITH ANTICONVULSIVE AND ANTIALLERGIC/ANTIASTHMATIC EFFECT - Google Patents

PYRAZOLO(3,4-d)PYRIMIDINES WITH ANTICONVULSIVE AND ANTIALLERGIC/ANTIASTHMATIC EFFECT

Info

Publication number
BG104150A
BG104150A BG104150A BG10415000A BG104150A BG 104150 A BG104150 A BG 104150A BG 104150 A BG104150 A BG 104150A BG 10415000 A BG10415000 A BG 10415000A BG 104150 A BG104150 A BG 104150A
Authority
BG
Bulgaria
Prior art keywords
pyrazolo
anticonvulsive
antiallergic
pyrimidines
antiasthmatic effect
Prior art date
Application number
BG104150A
Other languages
Bulgarian (bg)
English (en)
Inventor
Thomas Arnold
Hans-Joachim Lankau
Manfred Menzer
Angelika Rostock
Christine Tober
Klaus Unverferth
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of BG104150A publication Critical patent/BG104150A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG104150A 1998-06-22 2000-02-10 PYRAZOLO(3,4-d)PYRIMIDINES WITH ANTICONVULSIVE AND ANTIALLERGIC/ANTIASTHMATIC EFFECT BG104150A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19827679A DE19827679A1 (de) 1998-06-22 1998-06-22 Adenosinrezeptoraffine, antikonvulsiv und antiallergisch/antiasthmatisch wirkende Pyrazolo[3,4-d]pyrimidine und Verfahren zu deren Herstellung
PCT/EP1999/003863 WO1999067243A1 (de) 1998-06-22 1999-06-04 Antikonvulsiv und antiallergisch/antiasthmatisch wirkende pyrazolo(3,4-d)pyrimidine
CZ2000594A CZ288195B6 (en) 1998-06-22 1999-06-04 Derivative of pyrazolo[3,4-d]pyrimidines exhibiting anticonvulsive a antiallergic/anti-asthmatic activity, process of its preparation and use
CA002297706A CA2297706A1 (en) 1998-06-22 2000-02-02 Anticonvulsive and antiallergic/anti-asthmatic pyrazolo-(3,4-d)pyrimidines having affinity for the adenosine receptor, and process for their preparation

Publications (1)

Publication Number Publication Date
BG104150A true BG104150A (en) 2000-12-29

Family

ID=27171156

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104150A BG104150A (en) 1998-06-22 2000-02-10 PYRAZOLO(3,4-d)PYRIMIDINES WITH ANTICONVULSIVE AND ANTIALLERGIC/ANTIASTHMATIC EFFECT

Country Status (26)

Country Link
US (1) US6054460A (ru)
EP (1) EP1005471B1 (ru)
JP (1) JP2002518499A (ru)
CN (1) CN1126753C (ru)
AT (1) ATE223412T1 (ru)
AU (1) AU748090B2 (ru)
BG (1) BG104150A (ru)
BR (1) BR9906552A (ru)
CA (2) CA2301107A1 (ru)
CZ (1) CZ288195B6 (ru)
DE (2) DE19827679A1 (ru)
DK (1) DK1005471T3 (ru)
EA (1) EA002768B1 (ru)
ES (1) ES2182541T3 (ru)
HU (1) HUP0003783A3 (ru)
IL (1) IL134439A0 (ru)
NO (1) NO314760B1 (ru)
NZ (1) NZ502880A (ru)
PL (1) PL338897A1 (ru)
PT (1) PT1005471E (ru)
RU (1) RU2194050C2 (ru)
SK (1) SK283506B6 (ru)
TR (1) TR200000473T1 (ru)
TW (1) TW449476B (ru)
WO (1) WO1999067243A1 (ru)
ZA (1) ZA200000742B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042092A1 (de) * 2000-08-26 2002-03-07 Dresden Arzneimittel Antikonvulsiv wirkende 2,5-Dihydro-pyrazolo(3,4-d)pyrimidin-4-one und Verfahren zu deren Darstellung
WO2012125400A1 (en) * 2011-03-14 2012-09-20 Acorn Biomedical, Inc. Compositions and methods using adenosine a3 receptor antagonists for the treatment of inflammatory eye diseases
CN106749271B (zh) * 2016-12-07 2019-04-05 青岛科技大学 一类[1,2,4]-三氮唑并[1,5-a]嘧啶酮类杂环化合物、其制备方法及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000192A1 (en) * 1986-06-26 1988-01-14 Warner-Lambert Company 5-SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDIN-7-ONES
DE19649460A1 (de) * 1996-11-26 1998-05-28 Bayer Ag Neue substituierte Pyrazolderivate

Also Published As

Publication number Publication date
AU748090B2 (en) 2002-05-30
DE59902538D1 (de) 2002-10-10
DK1005471T3 (da) 2002-10-14
EP1005471B1 (de) 2002-09-04
ATE223412T1 (de) 2002-09-15
TW449476B (en) 2001-08-11
CA2301107A1 (en) 1999-12-29
NO20000748L (no) 2000-04-07
WO1999067243A1 (de) 1999-12-29
PL338897A1 (en) 2000-11-20
BR9906552A (pt) 2000-08-15
CN1126753C (zh) 2003-11-05
IL134439A0 (en) 2001-04-30
CZ288195B6 (en) 2001-05-16
NO20000748D0 (no) 2000-02-15
PT1005471E (pt) 2003-01-31
HUP0003783A3 (en) 2001-08-28
AU4605499A (en) 2000-01-10
TR200000473T1 (tr) 2000-09-21
EA002768B1 (ru) 2002-08-29
NZ502880A (en) 2001-12-21
ES2182541T3 (es) 2003-03-01
RU2194050C2 (ru) 2002-12-10
CA2297706A1 (en) 2001-08-02
CZ2000594A3 (cs) 2000-10-11
EA200000249A1 (ru) 2000-08-28
HUP0003783A2 (hu) 2001-04-28
DE19827679A1 (de) 1999-12-23
CN1275128A (zh) 2000-11-29
NO314760B1 (no) 2003-05-19
SK2252000A3 (en) 2000-08-14
ZA200000742B (en) 2000-10-27
SK283506B6 (sk) 2003-08-05
US6054460A (en) 2000-04-25
EP1005471A1 (de) 2000-06-07
JP2002518499A (ja) 2002-06-25

Similar Documents

Publication Publication Date Title
DE69633860D1 (en) Oral aktive adenosinkinase-inhibitoren
AU9693998A (en) Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
CA2368843A1 (en) Neurotrophic substituted pyrimidines
WO2002006286A3 (en) IMIDAZO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
PL377239A1 (pl) Nowe amino-podstawione pochodne dihydropirymido [4,5-d]-pirymidynonu, ich wytwarzanie i zastosowanie jako środków framaceutycznych
CA2263561A1 (en) Thienopyrimidines
PL336230A1 (en) Novel chemical compounds
EP0813527A4 (en) 6-SUBSTITUTED PYRAZOLO (3,4-D) PYRIMIDIN-4-ONE, PREPARATIONS, METHOD AND USE THEREOF
HUP0004439A3 (en) 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
AU5501598A (en) Triazolo{4,5-(d)}pyrimidinyl derivatives and their use as medicaments
PL370535A1 (en) Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders
WO2006033795A3 (en) Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
NO20002702L (no) Tienopyrimidiner
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
CA2384037A1 (en) Pyrazolo[4,3-d]pyrimidines
WO2004092171A3 (en) Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosin e receptor antagonists
WO2002004453A3 (en) PYRROLO[3,4-d]PYRIMIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
BG104150A (en) PYRAZOLO(3,4-d)PYRIMIDINES WITH ANTICONVULSIVE AND ANTIALLERGIC/ANTIASTHMATIC EFFECT
MXPA03003198A (es) 3,4-dihidro-pirido [1,2-a]pirimidinas sustituidas.
MXPA03003199A (es) 3,4-dihidro-pirimido?11,2-a]pirimidinas y 3,4-dihidro-pirazino[1,2-a?3 pirimidinas sustituidas.
BR0113517A (pt) 2,5-dihidro-pirazolo[3,4-d] pirimidin-4-onas de efeito anticonvulsivo e processos para preparação dos mesmos
WO2004056821A3 (en) Quinolizidine derivatives
MX9709656A (es) Inhibidores de adenosina cinasa solubles en agua.
GB0126395D0 (en) Pyrazolo[4,3]pyrimidine derivatives and their use in treating disease